Survey of chronic pain in Chile – prevalence and treatment, impact

Por um escritor misterioso
Last updated 05 julho 2024
Survey of chronic pain in Chile – prevalence and treatment, impact
Background and aims The prevalence of chronic non-cancer pain has not been specifically reported in Chile. Methods In order to assess its prevalence and impact, we designed a tool based on previously published survey studies. We analyzed a sample of 784 subjects to determine the prevalence of chronic non-cancer pain, with a maximum variability of 50%, a confidence interval (CI) of 95%, and an estimation error of 3.5%. Finally, a cross-sectional cell phone survey was conducted on a nationally representative probability sample of 865 subjects of over 18 years, in November 2013. The prevalence of chronic non-cancer pain was estimated by using expansion factors according to national projections by age group and gender, from the Chilean National Institute of Statistics for the year 2010. Results The estimated prevalence of chronic non-cancer pain was 32.1% (95% CI: 26.5–36.0). The respondents with chronic non-cancer pain presented the following results: 65.7% had moderate pain, and 20.8%, severe pain; 65.6% had somatic pain, 31.7% neuropathic pain, and 2.7% visceral pain. Approximately 70% reported they were receiving some kind of pharmacological treatment with certain frequency. In 64.9%, medication was prescribed by a physician. The prevalence of sick leave in workers was 30.22%, with a median duration of 14 days (interquartile range: 14; range: 1–60). Conclusions Chronic non-oncological pain occurs in 32% of Chilean adults. These figures provide the first measurement of chronic non-cancer pain in the Chilean population. Implications Chronic non-oncological pain impact as a public health problem is revealed, given the high prevalence found, and the elevated private and social costs involved.
Survey of chronic pain in Chile – prevalence and treatment, impact
Impact of parasitic infection on mental health and illness in humans in Africa: a systematic review, Parasitology
Survey of chronic pain in Chile – prevalence and treatment, impact
Migraine Comorbidities Library - Association of Migraine Disorders
Survey of chronic pain in Chile – prevalence and treatment, impact
Percentage of cause and diagnosis associated with chronic pain with
Survey of chronic pain in Chile – prevalence and treatment, impact
Relationship between fatty acid intake and chronic neck/shoulder/upper limb pain without elevated CRP in a Japanese population: a cross-sectional analysis of the Shika study, Journal of Nutritional Science
Survey of chronic pain in Chile – prevalence and treatment, impact
Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease - e-SPEN Journal
Survey of chronic pain in Chile – prevalence and treatment, impact
Estimates of Pain Prevalence and Severity in Adults
Survey of chronic pain in Chile – prevalence and treatment, impact
Higher prevalence of dental caries and periodontal problems among refugees: A scoping review — JOGH
Survey of chronic pain in Chile – prevalence and treatment, impact
Effects of therapeutic alliance on clinical outcomes in patients with symptomatic knee osteoarthritis undergoing an exercise program: A randomized clinical trial protocol - Medwave
Survey of chronic pain in Chile – prevalence and treatment, impact
The Weight of Sadness: Understanding Depression Statistics in 2023 - TherapyDen
Survey of chronic pain in Chile – prevalence and treatment, impact
The prevalence and management of chronic pain in the Chinese population: findings from the China Pain Health Index (2020), Population Health Metrics
Survey of chronic pain in Chile – prevalence and treatment, impact
Characterizing the Contribution of Chronic Pain Diagnoses to the Neurologic Burden of Disease, Active Component, U.S. Armed Forces, 2009–2018
Survey of chronic pain in Chile – prevalence and treatment, impact
Glutamatergic systems in neuropathic pain and emerging non-opioid therapies - ScienceDirect

© 2014-2024 miaad.org. All rights reserved.